Long-term treatment with hepatic tumor promoters inhibits mitogenic responses of hepatocytes to acidic fibroblast growth factor and hepatocyte growth factor
- 31 August 1991
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 59 (2) , 103-108
- https://doi.org/10.1016/0304-3835(91)90173-f
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Responsiveness of hepatocytes to epidermal growth factor, transforming growth factor-beta and norepinephrine during treatment with xenobiotic hepatic tumor promotersCancer Letters, 1991
- Acidic fibroblast growth factor (HBGF‐1) stimulates DNA synthesis in primary rat hepatocyte culturesJournal of Cellular Physiology, 1990
- NH2-terminal amino acid sequence of rabbit hepatopoietin A, a heparin-binding polypeptide growth factor for hepatocytesBiochemical and Biophysical Research Communications, 1989
- Pharmacokinetics and distribution of heparin-binding growth factor I (endothelial cell growth factor) in the rat.Circulation Research, 1989
- Blockade of α-1 adrenergic receptor inhibits hepatic DNA synthesis stimulated by tumor promotersCarcinogenesis: Integrative Cancer Research, 1989
- Phenobarbital reduces EGF receptors and the ability of physiological concentrations of calcium to suppress hepatocyte proliferationCarcinogenesis: Integrative Cancer Research, 1988
- Influences of diethylnitrosamine on longevity of surrounding hepatocytes and progression of transplanted persistent nodules during phenobarbital promotion of hepatocarcinogenesisInternational Journal of Cancer, 1987
- [29] Collagen as a substrate for cell growth and differentiationPublished by Elsevier ,1982
- The Sequential Analysis of Cancer DevelopmentAdvances in Cancer Research, 1980
- Chapter 4 Preparation of Isolated Rat Liver CellsPublished by Elsevier ,1976